Development of valdecoxib topical gels: Effect of formulation variables on the release of valdecoxib

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue SUPPL. 1, 2010, Pages 70-73

  Setty, C Mallikarjuna ^a   Babubhai, S Rupal ^b   Pathan, Inayat Bashir ^c  

^a Saraswathi College of Pharmaceutical Sciences   (India)

^b NET Pharmacy College   (India)

^c MES College of Pharmacy   (India)

Author keywords

In vitro release; Topical gel; Valdecoxib

Indexed keywords

ALCOHOL; CARBOMER; HYDROXYPROPYLMETHYLCELLULOSE; PROPYLENE GLYCOL; VALDECOXIB;

ARTICLE; CONCENTRATION RESPONSE; DRUG FORMULATION; DRUG RELEASE; GEL; IN VITRO STUDY; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 77953400916     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Chen LC, Elliott RA, Ashcroft DM. Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control. J Clin Pharm Ther 2004; 3: 215-219.
2. Capone ML, Tacconelli S, Sciulli MG, Patrignani P. Clinical pharmacology of selective COX-2 inhibitors. Int J Immunopathol Pharmacol 2003; 2 Suppl: 49-58.
3. Goldstein JL, Eisen GM, Agarwal N, Stenson WF, Kent JD, Verburg KM. Reduced incidence of upper gastrointestinal ulcer complications with the COX-2 selective inhibitor, valdecoxib. Aliment Pharmacol Ther 2001; 5: 527-538.
4. Chavez ML, Carrie J. and Dekorte CJ. Valdecoxib: A Review. Clin Ther 2003; 25(3):817-851.
5. Jagtap SA, Chincholi S, Taneja PK, Ismail ND, Dongree N, Desai A. Evaluation of the efficacy, safety and tolerability of valdecoxib gel (1%) in adult patients with painful inflammatory joint disease. Ind J Med Assoc 2003; 101 (12):764-6.
6. Kulkarni PK, Pradeep K. Emulsion-gels as topical drug delivery vehicles-a review. Int J Pharm Edu 2002; 36 (3): 119-3.
7. Tas C, Ozkan Y, Savaser A, Baykara T. (2003). In vitro release studies of chlorpheneramine maleate from gels prepared by different cellulose derivatives. Il Farmaco. 58, 605-611.
8. Devarakonda B, Li N, De Villiers MM. Effect of polyamidoamine (PAMAM)dendrimers on the in vitro release of water-insoluble nifedipine from aueous gels. AAPS PharmSciTech. 6(3), E504-E512.
9. Ropke CD, Kaneko TM, Rodrigues RM, Dasilva VV, Barros S, Sawada TCH, Kato MJ, Barros SBM. Evaluation of percutaneous absorption of 4-nerolidylcathecol from four topical formulations. Int.J.Pharm 2004; 249: 109-116.
10. Ozsoy V, Gungor S, Cevher E. Vehicle effects on in vitro release of tiaprofemic acid from different topical formulations. Il Farmaco 2004; 59: 563-566.
11. Higuchi WI. Analisis of data on the medicament release from ointments. J Pharm Sci1 962; 51:802-804.
12. Guy, R.H., Hadgraft, J. Selection of drug candidates for transdermal drug delivery, In: Hadgraft, J., Guy, R.H. (Eds.), Transdermal drug delivery, developmental issues and research initiatives, Marcel Dekker, Basel. 1990.
13. Arellano A, Santoyo S, Martin C, Ygartua P. Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of Diclofenac sodium from carbopol gels. Eur.J.Pharm.Sci. 1998;7:129-135.
14. Goundaliya D.P, Pundarikakshudu K. Studies on penetration, characterization and transdermal permeation of Nimesulide from aqueous and emulgel. Ind.Drugs 2002; 39(9): 465-473.
15. Lippold B.C. How to optimize drug penetration through the skin. Pharm. Act. Helv 1992; 67: 294-300.
16. Campbell P.S, Chandrasekaran S.K.U.S. Dosage for administrating and percutaneous absorption enhancer. US patent 4379454.
17. Berner B, Mazzenga G.C, Otter J.H, Steffens R.J, Juang R.H, Ebert C.D. Ethanol:water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin. J Pharm Sci 1989; 78:402-407.
18. Williams A.C, Barry B.W. Penetration enhancers. Adv.Drug Deliv.Rev 2004 56,603-618.